Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

200 CDER Staff Say Goodbye To White Oak, For Now

This article was originally published in The Tan Sheet

Executive Summary

Approximately 200 employees in FDA's Center for Drug Evaluation and Research are exiled from the agency’s White Oak campus for the next few years due to overcrowding.

You may also be interested in...



FDA Headquarters Consolidation Does Not Slow Outside Rent Growth

President Obama’s budget requests less headquarters consolidation funding in fiscal 2015. Outside rent spending in the budget request increased from $116.4 million to $120.9 million due to “escalating costs in commercial rent, security, service contracts and utilities,” according to FDA’s congressional justification.

FDA Headquarters Consolidation Does Not Slow Outside Rent Growth

President Obama’s budget requests less headquarters consolidation funding in fiscal 2015. Outside rent spending in the budget request increased from $116.4 million to $120.9 million due to “escalating costs in commercial rent, security, service contracts and utilities,” according to FDA’s congressional justification.

FDA White Oak Construction Nears Completion, But Some Plans On Hold

The biodefense complex would remain on schedule for fiscal 2014 completion, but communications and logistical buildings included in the master plan would be on hold. FDA tells Congress the sprawling campus must receive necessary operational funds as more employees move there.

Related Content

Topics

UsernamePublicRestriction

Register

PS104715

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel